Clinical genitourinary cancer · 2026
Exploration of the Tumor Transcriptomic and Immune Landscape Following Repeated Transurethral Resection in Non-Muscle-Invasive Bladder Cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seo Jiwoo, Park Jin-Mo, Park Dong Jin, Seo Incheol, Kwon Se Yun
Аннотация
OBJECTIVE: To investigate the associations of repeated transurethral resection of bladder tumor (TURBT) and BCG treatment with molecular, immunological, and microbial landscapes of nonmuscle-invasive bladder cancer (NMIBC).
METHODS: Tumor and matched normal tissues from 24 NMIBC patients (primary TURBT, n = 12; repeated TURBT, n = 12) underwent RNA sequencing for transcriptomic and immune repertoire analyses. Urine samples were analyzed by 16S rRNA sequencing to characterize the urinary microbiome. Patients in the repeated TURBT group were further stratified by BCG treatment status (BCG-treated, n = 5; non-BCG, n = 7).
RESULTS: Repeated TURBT was associated with differences in transcriptomic reprogramming, immune remodeling, and urinary microbiome profiles compared with primary TURBT. Compared with primary tumors, repeated tumors exhibited a transcriptional shift from hypoxia- and metabolism-related pathways toward proliferative cell cycle programs and partial restoration of T and B cell receptor diversity. Microsatellite instability scores did not differ significantly between groups. BCG treatment primarily enhanced dendritic cell activation, reflecting innate immune stimulation without affecting adaptive repertoires. Urinary microbiome analysis revealed increased heterogeneity, with cyanobacteriota and Corynebacterium detected exclusively in patients who underwent repeated TURBT without BCG treatment.
CONCLUSION: In this exploratory cohort, repeated TURBT was associated with coordinated transcriptomic, immunologic, and microbial features in NMIBC. These preliminary findings suggest that surgical history may influence tumor-associated molecular and immune characteristics and warrant further investigation in larger, longitudinal studies.
METHODS: Tumor and matched normal tissues from 24 NMIBC patients (primary TURBT, n = 12; repeated TURBT, n = 12) underwent RNA sequencing for transcriptomic and immune repertoire analyses. Urine samples were analyzed by 16S rRNA sequencing to characterize the urinary microbiome. Patients in the repeated TURBT group were further stratified by BCG treatment status (BCG-treated, n = 5; non-BCG, n = 7).
RESULTS: Repeated TURBT was associated with differences in transcriptomic reprogramming, immune remodeling, and urinary microbiome profiles compared with primary TURBT. Compared with primary tumors, repeated tumors exhibited a transcriptional shift from hypoxia- and metabolism-related pathways toward proliferative cell cycle programs and partial restoration of T and B cell receptor diversity. Microsatellite instability scores did not differ significantly between groups. BCG treatment primarily enhanced dendritic cell activation, reflecting innate immune stimulation without affecting adaptive repertoires. Urinary microbiome analysis revealed increased heterogeneity, with cyanobacteriota and Corynebacterium detected exclusively in patients who underwent repeated TURBT without BCG treatment.
CONCLUSION: In this exploratory cohort, repeated TURBT was associated with coordinated transcriptomic, immunologic, and microbial features in NMIBC. These preliminary findings suggest that surgical history may influence tumor-associated molecular and immune characteristics and warrant further investigation in larger, longitudinal studies.